Ublituximab Improves Functional MS Score: New ULTIMATE Analy

The new anti-CD20 monoclonal antibody showed significant improvement in the multiple sclerosis functional composite (MSFC) score, a measure of disability, compared with teriflunomide.

Related Keywords

Stanford University , California , United States , University Of California San Francisco , Lawrence Steinman , Bruce Cree , Drug Administration , Research In Multiple Sclerosis , European Committee For Treatment , European Committee , Multiple Sclerosis , California San Francisco , Expanded Disability Status Scale , Multiple Sclerosis Ms , Us , Disability , Clinical Research , Clinical Trials , Linical Studies , Magnetic Resonance Imaging Mri , Magnetic Resonance Imaging , Ri , Maging Magnetic Resonance , Multiple Sclerosis Relapse , S Relapse , Elapse Of Multiple Sclerosis , Elapse Of Ms , Relapsing Remitting Multiple Sclerosis , Arms , Ultiple Sclerosis Relapsing Remitting , Europe , European , U S ,